Mar 27, 2025
$50 Million Gift from the Weill Family Foundation Establishes the Weill Cancer Hub East
Jun 12, 2024
Natural Compounds Found in Milk and Blueberries Synergistically Provide Protective Benefits Against UV Exposure
Nov 16, 2020
Biohaven Pharmaceuticals And Weill Cornell Medicine Collaborate To Initiate Proof Of Concept Trial With CGRP Receptor Antagonist In Plaque Psoriasis
Jul 30, 2020
Jeffrey S. Borer, MD, is being recognized by Continental Who's Who
Mar 31, 2020
Lymphoma Research Foundation (LRF) Funds 16 New Early Career Scientists from World-Leading Cancer Research Institutes
Mar 16, 2020
Bridge Medicines Enters Exclusive License Agreement with The Rockefeller University for Novel Epigenetic Leukemia Program
Jan 07, 2020
HSS-Trained Physician for Boston Bruins, Boston Red Sox and New England Patriots Appointed Medical Director of HSS Florida
Dec 19, 2019
Hoth Therapeutics Enters into Research Collaboration Agreement with Weill Cornell Medicine to Examine the Efficacy of RAMBA in Blocking Acne Pathogenic Gene Expression
Sep 16, 2019
Weill Cornell Medicine Eliminates Medical Education Debt for All Qualifying Students
Apr 09, 2019
NewYork-Presbyterian and Columbia University Irving Medical Center Open New Sports Medicine and Performance Training Facility in Westchester
Mar 21, 2019
High-Fructose Corn Syrup Promotes Colon Tumor Growth in Mice
Mar 11, 2019
Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator
Jan 24, 2019
NewYork-Presbyterian Hospital expands virtual care with Philips
Nov 29, 2018
Dr. Said Ibrahim Named Inaugural Senior Associate Dean for Diversity and Inclusion
May 30, 2018
HSS to Honor Paul M. Pellicci, MD, Chief Emeritus of the Hip Service, and Senator William W. Bradley at Tribute Dinner on June 4
May 02, 2018
NYC Consortium joins NIH in launching the All of Us Research Program to advance precision medicine
Apr 03, 2018
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
Mar 14, 2018
Bridge Medicines Accepts Novel Small Molecule Targeting Basal Cell Carcinoma As First Drug Candidate for Development
Feb 28, 2018
Gale and Ira Drukier Prize in Children's Health Research Awarded to Harvard Hematologist
Jan 29, 2018
Weill Cornell Medicine Joins TriNetX Health Research Network to Expand Breadth of Clinical Research